DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1

Allison V Mitchell1, Jason Wu1,2, Fanyan Meng3

  • 1Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, 4100 John R, Detroit, MI 48201.

Insights

FOXQ1 and SNAI1 are independent transcription factors driving epithelial-mesenchymal transition (EMT). They co-regulate DDR2, a receptor tyrosine kinase crucial for cell motility and metabolism in triple-negative breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Epithelial-mesenchymal transition (EMT) is crucial in cancer progression.
  • The roles and interactions of transcription factors (TFs) in EMT are not fully understood.
  • Understanding TF interdependence is key to targeting cancer metastasis.

Purpose of the Study:

  • To investigate the interdependence of FOXQ1 and SNAI1 in EMT.
  • To identify shared downstream targets of FOXQ1 and SNAI1.
  • To elucidate the role of DDR2 in FOXQ1/SNAI1-driven EMT and triple-negative breast cancer (TNBC).

Main Methods:

  • Analysis of transcription factor interactions in EMT models.
  • Gene expression profiling and coexpression signature analysis.
  • Functional assays assessing cell motility, morphology, and stem cell populations.
  • Metabolic profiling following DDR2 knockdown.

Main Results:

  • FOXQ1 and SNAI1 function independently in EMT, upregulating common EMT TFs without reciprocal influence.
  • DDR2 is identified as a shared downstream effector of FOXQ1 and SNAI1, and the most upregulated receptor tyrosine kinase in TNBC.
  • DDR2 alteration profoundly impacts cell motility but not EMT markers, morphology, or stem cell populations.
  • DDR2 knockdown significantly alters global metabolism, including amino acid recycling.

Conclusions:

  • FOXQ1 and SNAI1 are independent drivers of EMT with a shared mechanism involving DDR2.
  • DDR2 plays a critical role in regulating cell motility and metabolism downstream of FOXQ1 and SNAI1 in TNBC.
  • Targeting DDR2 may offer a therapeutic strategy for modulating TNBC cell motility and metabolism.